Alnylam Pharmaceuticals (ALNY) shares outstanding

Shares outstanding · fiscal 2025
134.68M

Alnylam Pharmaceuticals (ALNY) had 134.68M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.5% higher than the 127.65M of fiscal 2024. Figures as of 18 Nov 2026, 12:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
134.68M
Change on fiscal 2024
+5.5%
Growth, 5 years
+3.2% a year
Highest on record
134.68Mfiscal 2025
Lowest on record
109.26Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Alnylam Pharmaceuticals shares outstanding, in more detail

The market data feed counts 133.94M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 3.2% a year. Across the 7 fiscal years on record (2019–2025), the highest was 134.68M in fiscal 2025 and the lowest 109.26M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

Alnylam Pharmaceuticals shares outstanding, year by year

Alnylam Pharmaceuticals (ALNY) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025134.68M 5.5% up
2024127.65M 2.2% up
2023124.91M 2.6% up
2022121.69M 2.7% up
2021118.45M 3.0% up
2020114.99M 5.2% up
2019109.26M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Alnylam Pharmaceuticals and comparable companies
CompanyShares outstandingFiscal year
Tenet Healthcare THC90.83M2025
BioNTech BNTX241.70M2025
Guardant Health GH125.37M2025
Alnylam Pharmaceuticals ALNY134.68M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ALNY

Alnylam Pharmaceuticals, figure by figure

Alnylam Pharmaceuticals (ALNY) overview: price, valuation and scorecardAll health care companies by market value

Alnylam Pharmaceuticals shares outstanding: questions and answers

How many shares does Alnylam Pharmaceuticals have?

Alnylam Pharmaceuticals (ALNY) had 134.68M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.5% higher than the 127.65M of fiscal 2024. The market data feed counts 133.94M shares outstanding today.

What is the growth rate of Alnylam Pharmaceuticals's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 3.2% a year.

What are the highest and lowest diluted share count figures on record for Alnylam Pharmaceuticals?

Across the 7 fiscal years on record (2019–2025), the highest was 134.68M in fiscal 2025 and the lowest 109.26M in fiscal 2019.

How is Alnylam Pharmaceuticals's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Alnylam Pharmaceuticals it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alnylam Pharmaceuticals (ALNY) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/ALNY/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.